Neurocrine's new awareness campaign for CAH includes similarly themed patient and physician websites (courtesy Neurocrine)

Neu­ro­crine launch­es CAH rare dis­ease ed­u­ca­tion cam­paign ahead of FDA sub­mis­sion

Neu­ro­crine Bio­sciences’ new­ly-de­buted cam­paign ac­knowl­edges the frus­tra­tion that con­gen­i­tal adren­al hy­per­pla­sia (CAH) pa­tients, fam­i­lies and en­docri­nol­o­gists of­ten feel.

The “What the C@H?!” theme is a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.